Metastatic Tumor Research and Outcomes Network



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:12/26/2018
Start Date:November 15, 2017
End Date:December 2019
Contact:Daniela Voegtli
Email:daniela.voegtli@aofoundation.org
Phone:+41 81 414 25 10

Use our guide to learn which trials are right for you!

Metastatic Tumor Research and Outcome Network A Multicenter Prospective Registry for the Management and Outcome of Metastatic Spine Tumors

The registry aims to collect patient information such as patient demographics,
co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse
events and HRQOL outcomes specific for patients with metastatic spine tumor(s).

To prospectively determine the prognostic variables (clinical, diagnostic, and therapeutic)
within patients diagnosed with metastatic spine tumor(s) that are associated with:

- patient reported outcomes (HRQOL)

- morbidity data

- local tumor control

- survival

Outcome measures:

Variables which will be collected in the registry that are applicable to patients with
metastatic spine tumor include:

- • Patient details

- Details of previous treatment

- Diagnosis

- Symptoms

- Treatment details for the index target

- Imaging information

The following outcome measures will be collected:

- Patient reported outcomes:

- Euroqol EQ-5D-3L

- Euroqol EQ-5D VAS - Quality of Life

- Neck Pain Numeric Rating Scale (NRS)

- Arm Pain NRS

- Back Pain NRS

- Leg Pain NRS

- SOSGOQ

- Patient assessment

- Ambulation

- Pain medication

- Nutritional Status Tool (PG-SGA©)

- Morbidity data

- Local disease recurrence data

- Overall survival data

Inclusion Criteria:

- Patient 18 or older.

- Patient diagnosed with a metastatic tumor of the spine

- Informed consent obtained, i.e.:

- Ability to understand the content of the patient information/ICF

- Willingness and ability to participate in the registry according to the Registry
Plan

- Signed and dated EC/IRB approved written informed consent (if consent is required
by the EC/ IRB at the registry site)

Exclusion Criteria:

• Patient diagnosed with a primary tumor of the spine.
We found this trial at
12
sites
Chicago, Illinois 60612
Principal Investigator: John O`Toole, MD
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Baltimore, Maryland 21205
Principal Investigator: Daniel M Sciubba, MD
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
25 Shattuck Street
Boston, Massachusetts 02114
Principal Investigator: John Shin, MD
Phone: 617-803-7021
?
mi
from
Boston, MA
Click here to add this to my saved trials
Clayton, Victoria 3800
Principal Investigator: Tony Goldschlager, MD
?
mi
from
Clayton,
Click here to add this to my saved trials
1515 Holcombe Boulevard
Houston, Texas 77030
Principal Investigator: Laurence D Rhines, MD
?
mi
from
Houston, TX
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Ilay Laufer, MD
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: James Schuster, MD
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
222 Richmond Street
Providence, Rhode Island 02903
Principal Investigator: Ziya Gokaslan, MD
?
mi
from
Providence, RI
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Michelle Clarke, MD
?
mi
from
Rochester, MN
Click here to add this to my saved trials
601 Elmwood Avenue
Rochester, New York 14642
Principal Investigator: Addisu Mesfin, MD
?
mi
from
Rochester, NY
Click here to add this to my saved trials
San Francisco, California 94143
Principal Investigator: Dean Chou, MD
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Valhalla, New York 10595
Principal Investigator: Meic Schmidt, MD
Phone: 914-493-5098
?
mi
from
Valhalla, NY
Click here to add this to my saved trials